Upcoming events
GTST Fireside Edition, December 14th.
Speakers: Tony Bosman, Carlijn Bouten and John Bell
Guided tour through our state-of-the-art laboratory
Networking!
Latest news
€1.4 million for acceleration of VivArt-X research
The Eindhoven startup VivArt-X will work with Smart BioMaterials Consortium (SBMC) and Eindhoven University of Technology (TU/e) over the next three years on the accelerated development of a synthetic biomaterial for forming healthy breast tissue after breast surgery....
Spheres4Life teams up with SBMC to study cell culture medium
Spheres4Life, a biomedical startup based in Enschede, is collaborating with SBMC on a feasibility study to validate the safety of S4, a special cell culture medium used in biomedical research. If the medium passes this safety test, the company will be able to start...
“Collaboration between experts in different domains is the key”
Jan de Boer is full professor at the department of Biomedical Engineering of Eindhoven University of Technology, where he leads the research group BioInterface Science. He is an experienced University Professor and Chief Scientific Officer with a demonstrated history...
Latest news
€1.4 million for acceleration of VivArt-X research
The Eindhoven startup VivArt-X will work with Smart BioMaterials Consortium (SBMC) and Eindhoven University of Technology (TU/e) over the next three years on the accelerated development of a synthetic biomaterial for forming healthy breast tissue after breast surgery....
Spheres4Life teams up with SBMC to study cell culture medium
Spheres4Life, a biomedical startup based in Enschede, is collaborating with SBMC on a feasibility study to validate the safety of S4, a special cell culture medium used in biomedical research. If the medium passes this safety test, the company will be able to start...
“Collaboration between experts in different domains is the key”
Jan de Boer is full professor at the department of Biomedical Engineering of Eindhoven University of Technology, where he leads the research group BioInterface Science. He is an experienced University Professor and Chief Scientific Officer with a demonstrated history...
“It’s not about money or opportunities; it’s about making a difference.”
STENTiT, one of the initial members of SBMC, develops a treatment of patients suffering from critical limb ischemia that had the potential to precent thousands of amputations worldwide. With CEO, and co-founder Bart Sanders, we delved into the latest news regarding...
About SBMC
Smart Biomaterials Consortium (SBMC) facilitates researchers, entrepreneurs, leading companies and strategic investors working together on the development and clinical production of smart biomaterials that will radically change the future of healthcare.
SBMC enables product development through shared translational platforms that address the key bottlenecks in commercialization of regenerative medicine.
We offer high-quality facilities for industrialization of smart biomaterials and biodegradable implants used for regenerative medicine-based technologies.
Our team is comprised of dedicated scientists, process engineers, operators, quality staff, and other support functions. They bring years of extensive experience in regenerative medicine and smart biomaterial development and manufacturing. Excellent expertise of academic research institutes is involved and committed to support SBMC.
By partnering with leading research institutions and launching new ventures, SBMC accelerates the translation of promising technologies, processes, and therapies into life-changing health outcomes.
Looking for new business opportunities?
Contact Olga Liska-Luzi, Business Developer
E-mail: bd@